Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa.

ABSTRACT:

Introduction

Adolescents and young adults aged <25 are a key population in the HIV epidemic, with very high HIV incidence rates in many geographic settings and a large number who have limited access to prevention services. Thus, any biomedical HIV prevention approach should prepare licensure and implementation strategies for young populations. Oral pre-exposure prophylaxis (PrEP) is the first antiretroviral-based prevention intervention with proven efficacy across many settings and populations, and regulatory and policy approvals at global and national levels are occurring rapidly. We discuss available data from studies in the United States and South Africa on the use of oral PrEP for HIV prevention in adolescent minors, along with some of the implementation challenges.

Discussi

SUBMITTER: Hosek S 

PROVIDER: S-EPMC5071778 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature